Based only on the facts in our directory. The right pick still depends on the job you need done.
Lower starting price
Not comparable
Not comparable: Paige does not list a price
Free plan
Tie
Neither has one
Higher rating
PathAI
4.1 against 4.3
Same job?
Yes
Both are Healthcare AI tools
Side by side
Compared on
Paige
PathAI
Our rating
4.1
4.3Better
Starts at
Not listed
Not listed
Free plan
No
No
Category
Healthcare AI
Healthcare AI
Plans
See pricing
See pricing
Key features
Paige Alba AI co-pilot for digital pathology tissue-slide analysis
Cancer diagnosis, tissue subtyping, and molecular biomarker discovery support
Founded in 2017 by researchers from Memorial Sloan Kettering Cancer Center
Acquired by Tempus in August 2025, continuing under its own brand
Enterprise deployment with dedicated support for hospital and lab pathology teams
AISight Dx analyzes digital pathology slide images to assist diagnosis
FDA 510(k) clearance for primary diagnosis in clinical settings, June 2025
Predetermined Change Control Plan allows faster future software updates
Expanded Labcorp collaboration deploying nationwide as of February 2026
FDA Breakthrough Device Designation for PathAssist Derm dermatopathology tool
Pros
Research pedigree from Memorial Sloan Kettering lends real clinical credibility
Tempus backing adds financial resources and precision-medicine data integration
Deep oncology pathology specialization outperforms general-purpose medical imaging AI
Genuine FDA clearance for primary diagnosis, not just an assistive tool
Predetermined Change Control Plan speeds up future regulatory-approved updates
National-scale deployment through Labcorp validates real clinical trust
Cons
Enterprise-only pricing requires a sales conversation before evaluation
Now part of a larger company, a real change from its independent-startup years
Narrow pathology focus means it's not a fit for non-oncology diagnostic workflows
Enterprise quote-based pricing requires a sales conversation, no published rates
Built specifically for pathology labs, not applicable to other clinical specialties
Regulatory-cleared medical device status means slower iteration than software-only tools
Company
Paige, founded 2017
PathAI, founded 2016
Prices come from each vendor's pricing page, last checked 20260716. Check the vendor before you buy.
FAQ
Questions people ask
Is Paige better than PathAI?
In our reviews Paige scores 4.1 and PathAI scores 4.3. The better pick depends on the job. Paige: Digital pathology AI co-pilot from Memorial Sloan Kettering researchers, acquired by Tempus in 2025. PathAI: First AI pathology platform FDA-cleared for primary diagnosis, now deployed nationwide via Labcorp.
PathAI
Paige
